Diabetes Board decisions

The Board has denied the Veteran's claim for service connection for diabetes mellitus type II, finding that there is no evidence of a chronic disability in service or within one year after separation. The Board also found that the current diagnosis is not related to any in-service injury or disease and concluded that it was more likely secondary to his service-connected depression, anxiety, and obstructive sleep apnea.

The Board denied the Veteran's claims for an increased rating for tinnitus and a compensable rating for bilateral hearing loss, but remanded the claim for service connection for diabetes.

The Board denied service connection for diabetes mellitus, hypertension, heart disorder, kidney disease, nephropathy, right lower extremity diabetic peripheral neuropathy, and left lower extremity diabetic peripheral neuropathy as there was no evidence of in-service incurrence or aggravation of these conditions.

The Veteran is granted TDIU from December 8, 2020 and SMC at the housebound rate from June 24, 2021 due to his service-connected PTSD and other disabilities.

The Board has determined that the Veteran's service-connected disabilities do not require regular aid and attendance, thus denying his claim for special monthly compensation based on aid and attendance.

The Board has granted service connection for Nonalcoholic Fatty Liver Disease (NAFLD) as secondary to the Veteran's service-connected Diabetes Mellitus, Type II. The decision is based on a finding that NAFLD was caused by or aggravated by his service-connected diabetes mellitus.

The Board remands the claim for an updated VA medical opinion and a toxic exposure risk activity (TERA) opinion due to the Veteran's presumptive toxic exposure as conceded by VA.

The Board dismissed the appeal for an earlier effective date for service connection for ischemic heart disease and diabetes mellitus type II prior to August 10, 2022, due to lack of subject matter jurisdiction.

The Board denied a rating higher than 30 percent for bilateral postoperative cataracts and diabetic retinopathy prior to May 5, 2016.

The Board denied service connection for the cause of the Veteran's death, as there was no evidence that any of the listed causes of death were related to his military service.

The Veteran's skin disability is related to service and granted. The claims for depression, anxiety, bilateral hearing loss, tinnitus, diabetes mellitus, hemorrhoids, diverticular disability, erectile dysfunction, prostate cancer, bladder cancer, gall bladder disability, and hernia are denied.

The Veteran's tinnitus and bilateral hearing loss claims are denied as there is no persuasive evidence linking these conditions to service.,The Veteran's severe depression, type II diabetes mellitus, left hand tingling, left leg numbness and tingling, and right leg numbness and tingling claims are remanded for further development.

The Veteran's claims for service connection for gastroesophageal reflux disease (GERD) and diabetes mellitus, type II are being remanded due to pre-decisional duty to assist errors. Specifically, a VA examination is required in accordance with the PACT Act for GERD, and an adequate medical opinion must be obtained regarding the Veteran's diabetes mellitus, type II and her in-service toxic exposure risk activities (TERAs).

The Board denied an earlier effective date for service connection due to the Veteran's character of discharge being a bar to VA benefits, and there was no new and material evidence received within one year of relevant decisions.

The appeals for service connection for optic atrophy, diabetes, and toxic exposure claims were dismissed due to untimely filings. The appeal for lipoma was remanded for further evidence.

The Board denied an increased disability rating in excess of 20 percent for diabetes mellitus, type I as the evidence did not show that the Veteran's condition required one or more daily injections of insulin, restricted diet, and regulation of activities.

The Veteran's appeals for increased disability ratings for diabetic peripheral neuropathy of the right and left upper extremities have been dismissed due to a request for withdrawal.

The Board has granted service connection for Nonalcoholic Fatty Liver Disease (NAFLD) as secondary to the Veteran's service-connected Diabetes Mellitus, Type II. The decision is based on a finding that NAFLD was at least as likely as not caused by his service-connected diabetes mellitus.

The Veteran's service-connected diabetic peripheral neuropathy of the right and left sciatic nerves, as well as his prostate cancer, are rated at specific levels prior to June 10, 2021.,Special monthly compensation (SMC) at the housebound rate is granted from August 30, 2018 to November 1, 2021.

The appeal as to the issue of entitlement to compensation for diabetes mellitus type II was dismissed because the Veteran did not establish good cause for extending the period to file a Notice of Disagreement.